Crispr Sickle Cell Treatment Receives FDA Approval

The approval signifies a new era of medicine.

This significant development in medical technology marks a pivotal moment in the treatment of genetic diseases. The therapy uses CRISPR, a revolutionary gene-editing tool, to correct the mutation causing sickle cell disease. This is the first time such a treatment has received FDA approval, opening the door to potential cures for other genetic condition…